• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 13F-HR filed by Blackstone Inc.

    11/14/25 4:01:05 PM ET
    $BX
    Investment Managers
    Finance
    Get the next $BX alert in real time by email
    SEC FORM 13F-HR

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 13F

    FORM 13F COVER PAGE

    OMB APPROVAL
    OMB Number: 3235-0006
    Estimated average burden
    hours per response: 23.8

    Report for the Calendar Year or Quarter Ended: 09-30-2025
    Check here if Amendment    Amendment Number:
    This Amendment (Check only one.):    is a restatement.
       adds new holdings entries.
    Institutional Investment Manager Filing this Report:
    Name: Blackstone Inc.
    Address: 345 PARK AVENUE
    NEW YORK, NY  10154
    Form 13F File Number: 028-13114
    CRD Number (if applicable):
    SEC File Number (if applicable): 028-13114

    The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

    Person Signing this Report on Behalf of Reporting Manager:
    Name: Victoria Portnoy
    Title: Managing Director - Assistant Secretary
    Phone: 212-583-5000
    Signature, Place, and Date of Signing:
    /s/ Victoria Portnoy New York,  NY 11-14-2025
    [Signature] [City, State] [Date]
    The Oatly Group AB position reported in this filing reflects the number of American Depository Shares that may be received in exchange for the reporting manager's holding of Ordinary Shares. The following information corresponds to the securities indicated in the attached Information Table: (A) Options reported in this Form 13F may include more than one series of call or put options, as applicable, with respect to such issuer. (B) The information contained in this Form 13F relating to the investment discretion by certain other reporting managers may reflect information relating to certain of their affiliates.
    Report Type (Check only one.):
    X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
       13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
       13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
    Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
    Form 13F Summary Page
    Report Summary:
    Number of Other Included Managers: 9
    Form 13F Information Table Entry Total: 263
    Form 13F Information Table Value Total: 24,843,445,803
    (round to nearest dollar)
    List of Other Included Managers:
    Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
    [If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
    No. Name Form 13F File No. CRD No. (if applicable) SEC File No. (if applicable) CIK
    1 Blackstone Alternative Credit Advisors LP 28-12332 000137519    
    2 Blackstone Management Partners L.L.C. 28-17363 000136978    
    3 Clarus Ventures, LLC 28-16028 000160980    
    4 Blackstone Alternative Solutions L.L.C. 28-19316 000158784    
    5 Blackstone Real Estate Advisors L.P. 28-20287 000142979    
    6 Harvest Fund Advisors LLC 28-13436 000154425    
    7 Blackstone Tactical Opportunities Advisors L.L.C. 28-20994 000160157    
    8 Blackstone Infrastructure Advisors L.L.C. 28-20992 000289751    
    9 Blackstone Alternative Asset Management L.P. 28-22637 000107580    

    Get the next $BX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BX

    DatePrice TargetRatingAnalyst
    3/5/2026$126.00Equal Weight
    Barclays
    2/24/2026$179.00Outperform
    RBC Capital Mkts
    12/11/2025$175.00Neutral
    UBS
    10/3/2025$190.00Outperform
    BMO Capital Markets
    4/8/2025$165.00Mkt Perform → Mkt Outperform
    Citizens JMP
    3/17/2025$180.00Neutral → Buy
    UBS
    12/12/2024$188.00 → $195.00Overweight → Equal Weight
    Wells Fargo
    12/9/2024$149.00 → $230.00Hold → Buy
    TD Cowen
    More analyst ratings

    $BX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays resumed coverage on Blackstone with a new price target

    Barclays resumed coverage of Blackstone with a rating of Equal Weight and set a new price target of $126.00

    3/5/26 8:30:26 AM ET
    $BX
    Investment Managers
    Finance

    RBC Capital Mkts initiated coverage on Blackstone with a new price target

    RBC Capital Mkts initiated coverage of Blackstone with a rating of Outperform and set a new price target of $179.00

    2/24/26 7:45:48 AM ET
    $BX
    Investment Managers
    Finance

    UBS resumed coverage on Blackstone with a new price target

    UBS resumed coverage of Blackstone with a rating of Neutral and set a new price target of $175.00

    12/11/25 9:03:20 AM ET
    $BX
    Investment Managers
    Finance

    $BX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Blackstone Holdings Iv Gp Management (Delaware) L.P. bought $30,000,000 worth of Common Shares of Beneficial Interest (1,146,789 units at $26.16) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    2/24/26 6:33:14 PM ET
    $BX
    Investment Managers
    Finance

    Director Porat Ruth bought $68,553 worth of shares (525 units at $130.68), increasing direct ownership by 1% to 39,502 units (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Issuer)

    2/20/26 4:12:44 PM ET
    $BX
    Investment Managers
    Finance

    Large owner Blackstone Holdings Iv Gp Management (Delaware) L.P. bought $10,000,000 worth of Common Shares of Beneficial Interest (384,468 units at $26.01) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    12/22/25 4:59:31 PM ET
    $BX
    Investment Managers
    Finance

    $BX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blackstone Closes Flagship Opportunistic Credit Fund at Over $10B, Hitting Hard Cap

    Blackstone (NYSE:BX) today announced the final close of Blackstone Capital Opportunities Fund V ("COF V"), with over $10 billion of investable capital. The fund was oversubscribed and closed at its hard cap. This fundraise builds on Blackstone Credit & Insurance's ("BXCI") 20-year track record investing through market cycles. Blackstone's opportunistic credit strategy has generated a 13% net IRR since inception in 2007. Blackstone manages $520 billion of total assets across corporate and real estate credit. Lou Salvatore, Co-Portfolio Manager of the Capital Opportunities Funds said: "COF V is Blackstone's largest opportunistic credit fund raised to date, reflecting continued strong inst

    4/7/26 7:30:00 AM ET
    $BX
    Investment Managers
    Finance

    Blackstone Announces Top-Ranked Professional Golfer, Tommy Fleetwood, as Global Brand Ambassador

    Blackstone (NYSE:BX) today announced a new partnership with Tommy Fleetwood, world number four professional golfer. Tommy will serve as Blackstone's first ever global brand ambassador, supporting the company's multi-decade effort to bring its exceptional performance to private wealth investors. "Tommy Fleetwood exemplifies the qualities that define our firm and resonate with our clients—disciplined performance, fierce determination, and high ethical standards. That mindset reflects how we try to operate every day. We're genuinely excited to partner with someone who is committed to winning and doing it in the right way," said Jon Gray, President and Chief Operating Officer of Blackstone.

    3/31/26 8:15:00 AM ET
    $BX
    Investment Managers
    Finance

    Blackstone Announces Final Close of Record $6.3 Billion Life Sciences Fund – the Largest Private Fund Dedicated to Life Sciences

    — Oversubscribed fund reflects strong track record Blackstone (NYSE:BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed and closed at its hard cap of $6.3 billion of total capital commitments. It is the largest life sciences private fund ever raised and is nearly 40% larger than its predecessor vehicle. Nicholas Galakatos, Ph.D., Global Head of Blackstone Life Sciences ("BXLS"), said, "We are grateful to the BXLS VI investors for their strong support of our strategies and the firm's enduring conviction in the life sciences." He added, "Our partnerships with global leaders have produced 34 regulatory approvals of innovative medicines

    3/30/26 8:00:00 AM ET
    $BX
    Investment Managers
    Finance

    $BX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Porat Ruth

    4 - Blackstone Inc. (0001393818) (Issuer)

    4/3/26 5:47:39 PM ET
    $BX
    Investment Managers
    Finance

    SEC Form 4 filed by Lazarus Rochelle B

    4 - Blackstone Inc. (0001393818) (Issuer)

    4/3/26 5:42:38 PM ET
    $BX
    Investment Managers
    Finance

    SEC Form 4 filed by Parrett William G

    4 - Blackstone Inc. (0001393818) (Issuer)

    4/3/26 5:39:43 PM ET
    $BX
    Investment Managers
    Finance

    $BX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Blackstone Inc.

    SCHEDULE 13G/A - Blackstone Inc. (0001393818) (Subject)

    3/26/26 4:43:59 PM ET
    $BX
    Investment Managers
    Finance

    Blackstone Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Blackstone Inc. (0001393818) (Filer)

    3/24/26 4:18:16 PM ET
    $BX
    Investment Managers
    Finance

    SEC Form S-8 filed by Blackstone Inc.

    S-8 - Blackstone Inc. (0001393818) (Filer)

    2/27/26 4:38:18 PM ET
    $BX
    Investment Managers
    Finance

    $BX
    Financials

    Live finance-specific insights

    View All

    Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront

    The deal affirms Blackstone's vision of building companies around innovative products to meet unmet patient needs Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced today that Novartis has completed its acquisition of Anthos Therapeutics in a transaction valued at up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, a novel Factor XI inhibitor that originated at Novartis. Abelacimab is currently in Phase

    4/3/25 4:15:00 PM ET
    $BX
    Investment Managers
    Finance

    Blackstone Acquires Majority Stake in Leading Hotel Accounting Software and Services Provider M3

    Growth investment made in partnership with Asian American Hotel Owners Association (AAHOA) M3, LLC ("M3"), voted the number-one hospitality accounting software in North America, today announced it has signed a definitive agreement for a majority investment from Blackstone Growth and affiliated funds (collectively "Blackstone"). The investment will help to accelerate the company's growth by enhancing new product expansion and supporting the adoption of M3's software, which enables hotel operators to run more efficiently and effectively. AAHOA, representing nearly 20,000 hotel owners and 60% of hotels across the United States, will make its first ever strategic investment alongside Blacksto

    8/15/24 9:00:00 AM ET
    $BX
    Investment Managers
    Finance

    Blackstone Completes Acquisition of Tropical Smoothie Cafe

    Blackstone (NYSE:BX) announced today that private equity funds managed by Blackstone ("Blackstone") have completed the acquisition of Tropical Smoothie Cafe, a leading franchisor of fast casual restaurants, from Levine Leichtman Capital Partners. This marks the first transaction in Blackstone's most recent vintage of its flagship private equity vehicle. "Tropical Smoothie Cafe is a nationally recognized brand with an impressive growth trajectory underpinned by a base of loyal franchisees and guests," said Peter Wallace, a Senior Managing Director, and Michael Staub, a Managing Director, in Blackstone's Private Equity business. "With Blackstone's capital and resources, we look forward to a

    6/10/24 10:30:00 AM ET
    $BX
    Investment Managers
    Finance

    $BX
    Leadership Updates

    Live Leadership Updates

    View All

    Blackstone Announces Top-Ranked Professional Golfer, Tommy Fleetwood, as Global Brand Ambassador

    Blackstone (NYSE:BX) today announced a new partnership with Tommy Fleetwood, world number four professional golfer. Tommy will serve as Blackstone's first ever global brand ambassador, supporting the company's multi-decade effort to bring its exceptional performance to private wealth investors. "Tommy Fleetwood exemplifies the qualities that define our firm and resonate with our clients—disciplined performance, fierce determination, and high ethical standards. That mindset reflects how we try to operate every day. We're genuinely excited to partner with someone who is committed to winning and doing it in the right way," said Jon Gray, President and Chief Operating Officer of Blackstone.

    3/31/26 8:15:00 AM ET
    $BX
    Investment Managers
    Finance

    Blackstone Credit & Insurance Appoints Laura Coady as Global Head of CLOs and European Head of Liquid Credit Strategies

    Blackstone (NYSE:BX) announced today that Laura Coady, formerly Head of International Securitised Markets and Global Head of CLOs at Jefferies, has joined Blackstone Credit & Insurance ("BXCI") as Global Head of CLOs and European Head of Liquid Credit Strategies (LCS). Based in London, Coady will oversee BXCI's CLO activity globally, including CLO formation and investing, and lead the liquid credit business in Europe. BXCI's LCS business manages $120 billion across corporate bonds, leveraged loans, CLOs and Multi-Asset Credit. Blackstone is the largest global manager of CLOs and loans, and the most active loan trader. The firm set a record for global annual CLO issuance in 2024, beating t

    11/3/25 7:10:00 AM ET
    $BX
    Investment Managers
    Finance

    Blackstone Multi-Asset Investing (BXMA) Hires Monica Issar as Senior Managing Director

    Blackstone (NYSE:BX) today announced that Monica Issar will join Blackstone Multi-Asset Investing ("BXMA") as a Senior Managing Director based in New York where she will be the Head of Total Portfolio Management ("TPM"). Monica will join the TPM leadership team partnering closely with Co-Chief Investment Officers, Joe Dowling and David Ben-Ur. She will report directly to Joe Dowling, Global Head of Blackstone Multi-Asset Investing. "Monica is a proven leader with a remarkable track record of driving innovation in investment solutions and scaling multi-asset platforms," says Joe Dowling. "Her expertise will be pivotal in advancing BXMA's portfolio management capabilities and delivering val

    7/14/25 4:05:00 PM ET
    $BX
    Investment Managers
    Finance

    $BX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Blackstone Inc.

    SC 13G - Blackstone Inc. (0001393818) (Subject)

    11/13/24 3:07:30 PM ET
    $BX
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Blackstone Inc. (Amendment)

    SC 13G/A - Blackstone Inc. (0001393818) (Subject)

    2/13/24 4:55:49 PM ET
    $BX
    Investment Managers
    Finance

    SEC Form SC 13G filed by Blackstone Inc.

    SC 13G - Blackstone Inc. (0001393818) (Subject)

    1/29/24 3:26:26 PM ET
    $BX
    Investment Managers
    Finance